Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
241,700 New
241,700 $1.19 Million
Q2 2022

Aug 15, 2022

BUY
$4.02 - $5.21 $30,149 - $39,075
7,500 Added 17.65%
50,000 $223,000
Q1 2022

May 13, 2022

SELL
$5.0 - $9.26 $105,500 - $195,386
-21,100 Reduced 33.18%
42,500 $214,000
Q2 2021

Aug 16, 2021

BUY
$8.52 - $15.47 $541,872 - $983,892
63,600 New
63,600 $815,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.